Mafirakureva N, Lim AG, Khalid GG, Aslam K, Campbell L, et al.
2020-11-04 • Journal of Viral Hepatitis
2020-11-04 • Journal of Viral Hepatitis
Despite the availability of effective direct-acting antiviral (DAA) treatments for Hepatitis C virus (HCV) infection, many people remain undiagnosed and untreated. We assessed the cost-e...
Walker JG, Mafirakureva N, Iwamoto M, Campbell L, Kim CS, et al.
2020-05-31 • Liver International
2020-05-31 • Liver International
BACKGROUND & AIMS In 2016, Médecins Sans Frontières established the first general population Hepatitis C virus (HCV) screening and treatment site in Cambodia, offering free direct-ac...
Mafirakureva N, Stone J, Fraser H, Nzomukunda Y, Maina A, et al.
2020-06-29 • Society
2020-06-29 • Society
BACKGROUND AND AIMS Hepatitis C virus (HCV) treatment is essential for eliminating HCV in people who inject drugs (PWID), but has limited coverage in resource-limited settings. We me...
Lim AG, Walker JG, Mafirakureva N, Khalid GG, Qureshi H, et al.
2020-03-01 • Lancet Global Health
2020-03-01 • Lancet Global Health
BACKGROUND The WHO elimination strategy for hepatitis C virus advocates scaling up screening and treatment to reduce global hepatitis C incidence by 80% by 2030, but little is known ...
Marquez LK, Chaillon A, Soe KT, Johnson DC, Zosso JM, et al.
2021-02-01 • BMJ Global Health
2021-02-01 • BMJ Global Health
INTRODUCTION Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins San...
